Compumedics Limited provided earnings guidance for the year 2022. For the year, the company expects sales orders taken for FY22 expected to be at least $42 million, an, at least, 19% increase on FY21. Revenues expected to be around $35 million for FY22.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.24 AUD | 0.00% | -4.00% | -14.29% |
Feb. 29 | Compumedics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Jan. 11 | Compumedics Expects to Hit Record Fiscal H1 Revenue | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.29% | 28.42M | |
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- CMP Stock
- News Compumedics Limited
- Compumedics Limited Provides Earnings Guidance for the Year 2022